Meet The CEOs

Meet The CEOs

Download on the App Store

Meet The CEOs episodes

  • Revolutionary Welding Technology for the Nuclear, Aerospace & Defence Industries: K-TIG (ASX: KTG)
    Non-Executive Director Adrian Smith discusses how Keyhole TIG Welding (K-TIG) (ASX: KTG) is using its industry-disrupting welding technology is changing the economics of commercial fabrication. Adrian shares insights into the company's strong position in keys markets across the US and UK, its strategic growth priorities and recent achievements.
    K-TIG is the developer and manufacturer of a patented, high productivity welding technology known as Keyhole TIG. The company's advanced technology reduces multi-hour conventional TIG welds to just 3 minutes, whilst providing finishes to a quality standard which meets the most demanding requirements of the nuclear, aerospace & defence industries.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 24 June 2020 at 12pm AEST.
    20 min
  • Treating the Underlying Causes of Diseases: Nyrada Inc. (ASX: NYR)
    CEO James Bonnar outlines how Nyrada (ASX: NYR) is developing new therapies for cardiovascular and neurological disorders, why the company is well positioned within the global markets and what gives them a competitive edge. James also talks about the recent achievements and plans to transition into clinical study phases, and answers listeners questions.
    Nyrada Inc. is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases. The Company has two main programs, each targeting market sectors of significant size and considerable unmet clinical need.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 24 June 2020 at 12pm AEST.
    20 min
  • Leading High Precision Battery Technologies: Novonix (ASX.NVX)
    CEO Dr Chris Burns discusses how Novonix is delivering the high quality lithium-ions battery technologies needed by key renewable energies industries and a cleaner energy future. In this session, Chris covers why the Company is well positioned within a growing market, what gives them a competitive edge, and answers interesting questions from listeners.
    Novonix Limited (ASX.NVX) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in more than 14 countries.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 17 June 2020 at 12pm AEST.
    24 min
  • Airway Technology Transforming Personal Health: Rhinomed (ASX.RNO)
    CEO and Managing Director, Michael Johnson, outlines Rhinomed's rapid growth and global presence, and how it is targeting the large addressable markets in sport, sleep, nausea, allergy/congestion and respiratory issues. An exciting Melbourne company, Michael discusses Rhinomed's recent achievements, future prospects and strategic goals for the coming year.
    Rhinomed Limited (ASX.RNO) is a ASX listed airway technology company that has developed a simple and innovative nasal stent to improve air flow to the lungs and deliver therapeutic agents. The Company has established a leading position in sports performance enhancement, as testified by athletes including two-time Tour de France winner Chris Froome.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 17 June 2020 at 12pm AEST.
    18 min
  • Exciting Fintech Company providing Debt-Restructuring and Insolvency Management: Credit Intelligence Limited (ASX. CI1)
    Executive Chairman and Managing Director Jimmie Wong discusses Credit Intelligence's favourable position within key markets and macroeconomic conditions, it's expansions in Australia and Singapore, and a provides a general company update.
    Credit Intelligence Limited (ASX. CI1) is one of the leading diversified debt-restructuring and personal insolvency management services operating in Hong Kong in the credit funding sector. Credit Intelligence’s main business includes the provision of bankruptcy admission services and Individual Voluntary Arrangement (IVA) proposal consultancy and implementation services.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 17 June 2020 at 12pm AEST.
    17 min
  • Revolutionising the Treatment of Neurodegenerative Conditions: NeuroScienfitic Biopharmaceuticals (NSB.ASX)
    CEO and Managing Director Matthew Liddelow discusses how NeuroScienfitic is revolutionising the treatment of Alzheimer’s disease and optic nerve conditions through its lead drug candidate, called EmtinB. Providing insights into the Company's exciting developments and global collaborations, Matthew shares the successfully results achieved through preclinical trials and the plans to start clinical trails by the end of 2020.
    NeuroScienfitic Biopharmaceuticals Ltd (NSB.ASX) is a drug development company focused on developing novel peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 10 June 2020 at 12pm AEST.
    23 min
  • A Nimble Company with a Compelling Service Offering: Spirit Telecom (ST1.ASX)
    Managing Director Sol Lukatsky discusses why Spirit is Australia's leading provider of bundled IT and Telco services, the Company's strong position within key markets and its multi-channel distribution, and strategic plans for the coming year.
    Spirit Telecom (ST1.ASX) has been built on the simple premise that Australian businesses deserve better, faster and more reliable internet. Now firmly established as a challenger brand with the infrastructure and expertise to take on the industry giants, Spirit Telecom is accelerating its growth plans, via its digital platform Spirit X and through acquisitions.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 10 June 2020 at 12pm AEST.
    22 min
  • Australia’s Newest Gold & Silver Producer Announces IPO: Manuka Resources
    Executive Chairman Dennis Karp discusses the recently announced IPO, and the Company's huge exploration potential and capacity to expand its project sites.
    Manuka is Australia’s newest gold & silver producer and commenced production in April 2020 and is expected to mine and process over 30,000 ounces of gold in its first 12 months. The Company owns 100% of two, fully permitted Gold and Silver assets located in the Cobar Basin of NSW; has purchased the Wonawinta project in late 2016 and acquired Mt Boppy Resources P/L the holder of the high-grade historic Mt Boppy gold project, in mid-2019.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 10 June 2020 at 12pm AEST.
    18 min
  • Trusted Financial Information Sharing: Identitii (ID8.ASX)
    CEO John Rayment discusses how Identitii (ID8.ASX) is improving the integrity and security of data as it moves around the global financial systems, how they are well positioned in the market and what gives them a competitive edge.
    While money moves fairly freely around the world, the information needed to process and report on financial transactions is often incomplete, inaccurate or even missing. Identitii is helping to solve these issues by replacing manual processes with a global network for financial information that enhances existing systems and helps reduce financial crime, decrease operational costs and improve the integrity of data for financial institutions and regulators around the world.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 3 June 2020 at 12pm AEST.
    21 min
  • Transforming Payroll and Human Capital Management: PayGroup (PYG.ASX)
    Managing Director Mark Samlal discusses how PayGroup is revolutionising modern business practices and is well positioned to take advantage of current market opportunities.
    Headquartered in Melbourne, PayGroup is the holding company for PayAsia and Astute One. PayAsia delivers payroll solutions and a cloud-based human capital management platform, HROnline, to multinational clients of all employee sizes across Asia Pacific and the Middle East.
    Any advice contained within this presentation is general advice and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. The information we are giving you is for educational purposes only.
    Accurate time of recording, 3 June 2020 at 12pm AEST.
    21 min

About Meet The CEOs

From the publisher's feed

Get a seat at the table and hear directly from CEOs and business leaders. Each week we are joined by three CEOs of exciting ASX listed businesses, who provide valuable insight to their industries,…